HKSE - Delayed Quote HKD

MODERN CHI MED (1643.HK)

Compare
0.340
+0.025
+(7.94%)
At close: 3:59:25 PM GMT+8
Loading Chart for 1643.HK
  • Previous Close 0.315
  • Open 0.315
  • Bid 0.325 x --
  • Ask 0.340 x --
  • Day's Range 0.300 - 0.345
  • 52 Week Range 0.245 - 0.600
  • Volume 8,898,000
  • Avg. Volume 2,786,440
  • Market Cap (intraday) 204M
  • Beta (5Y Monthly) 0.39
  • PE Ratio (TTM) 17.00
  • EPS (TTM) 0.020
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 25, 2022
  • 1y Target Est --

Modern Chinese Medicine Group Co., Ltd., an investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China. The company offers vigour and vitality supplement, circulation enhancement, kidney invigoration, menstrual discomfort relief, huoxiang zheng qi, liver-dispersing and stomach regulating, and fever- removing and detoxification pills; cardiotonic enhancement and heart wellness capsules; and liver detox tablets. It offers its products as therapeutics for the qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, and respiratory system conditions. It also provides business support, technical, and consulting services. The company was founded in 1986 and is headquartered in Chengde, China. Modern Chinese Medicine Group Co., Ltd. operates as a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.

www.cdysjdyy.com

190

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 1643.HK

View More

Performance Overview: 1643.HK

Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

1643.HK
10.53%
HANG SENG INDEX (^HSI)
3.10%

1-Year Return

1643.HK
6.25%
HANG SENG INDEX (^HSI)
20.67%

3-Year Return

1643.HK
49.96%
HANG SENG INDEX (^HSI)
5.44%

5-Year Return

1643.HK
70.94%
HANG SENG INDEX (^HSI)
14.89%

Compare To: 1643.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1643.HK

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    189.00M

  • Enterprise Value

    -54.98M

  • Trailing P/E

    18.41

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.83

  • Price/Book (mrq)

    0.37

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.52%

  • Return on Assets (ttm)

    2.79%

  • Return on Equity (ttm)

    2.02%

  • Revenue (ttm)

    214.07M

  • Net Income Avi to Common (ttm)

    9.67M

  • Diluted EPS (ttm)

    0.020

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    229.67M

  • Total Debt/Equity (mrq)

    0.03%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 1643.HK

View More

Company Insights: 1643.HK

Research Reports: 1643.HK

View More

People Also Watch